High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer
U. Bick, C. Engel, B. Krug, W. Heindel, E. M. Fallenberg, K. Rhiem, D. Maintz, M. Golatta, D. Speiser, D. Rjosk-Dendorfer, I. Lämmer-Skarke, F. Dietzel, K. Werner, F. Schäfer, E. Leinert, S. Weigel, S. Sauer, S. Pertschy, T. Hofmockel, A. Hagert-Winkler, K. Kast, A. Quante, A. Meindl, M. Kiechle, M. Loeffler, R. K. Schmutzler, the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)
Breast Cancer Res Treat (2019). doi: 10.1007/s10549-019-05152-9
Strukturierte und qualitätsgesicherte Früherkennung: Eine wichtige Säule im Kampf gegen Brustkrebs
W. Heindel, C. Verloh, S. Weigel
Onkologische Pharmazie; 21. Jahrgang; Nr. 1/2019; ISSN-Nr. 1437-8825
Time trend in programme sensitivity within the German mammography screening programme in North Rhine-Westphalia and Lower Saxony
B. Bokhof, L. Khil, I. Urbschat, L. Gnas, G. Hecht, O. Heidinger, W. Heindel, J. Kieschke, S. Weigel, H.W. Hense
Bundesgesundheitsbl (2018) 61: 1517. doi: 10.1007/s00103-018-2843-7
Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval
A. Prange, B. Bokhof, P. Polzer, J. Tio, I. Radke, O. Heidinger, W. Heindel, S. Weigel
Rofo. 2018; 190. doi: 10.1055/a-0657-3970
Evaluation of the New DIN Standard for Quality Assurance of Diagnostic Displays – Technical Review DIN 6868-157
K. Entz, A. Sommer, H. Lenzen
Fortschr Röntgenstr 2018; 190(01): 51-60; DOI: 10.1055/s-0043-110862
Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial
S. Weigel, J. Gerss, H.W. Hense, M. Krischke, A. Sommer, J. Czwoydzinski, H. Lenzen, L. Kerschke, K. Spieker, S. Dickmaenken, S. Baier, M. Urban, G. Hecht, O. Heidinger, J. Kieschke, W. Heindel
BMJ Open 2018;8:e020475. doi: 10.1136/bmjopen-2017-020475